BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26088127)

  • 21. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L; Hutzen B; Zuo M; Ball S; Deangelis S; Foust E; Pandit B; Ihnat MA; Shenoy SS; Kulp S; Li PK; Li C; Fuchs J; Lin J
    Cancer Res; 2010 Mar; 70(6):2445-54. PubMed ID: 20215512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X; Zhang J; Wang L; Wei H; Tian Z
    BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of STAT1 by the FRK tyrosine kinase is associated with human glioma growth.
    Hua L; Wang G; Wang Z; Fu J; Fang Z; Zhuang T; Zhao L; Zong Z; Ye C; Liu H; Zhu Y; Yu R
    J Neurooncol; 2019 May; 143(1):35-47. PubMed ID: 30993511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
    Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
    Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A specific STAT3-binding peptide exerts antiproliferative effects and antitumor activity by inhibiting STAT3 phosphorylation and signaling.
    Kim D; Lee IH; Kim S; Choi M; Kim H; Ahn S; Saw PE; Jeon H; Lee Y; Jon S
    Cancer Res; 2014 Apr; 74(8):2144-51. PubMed ID: 24576829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An anti-cancer WxxxE-containing azurin polypeptide inhibits Rac1-dependent STAT3 and ERK/GSK-3β signaling in breast cancer cells.
    Zhang Z; Luo Z; Min W; Zhang L; Wu Y; Hu X
    Oncotarget; 2017 Jun; 8(26):43091-43103. PubMed ID: 28549350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
    Fujita M; Zhu X; Sasaki K; Ueda R; Low KL; Pollack IF; Okada H
    J Immunol; 2008 Feb; 180(4):2089-98. PubMed ID: 18250414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells.
    Tang C; Xue HL; Huang HB; Wang XG
    Neurosci Lett; 2010 Feb; 470(2):126-9. PubMed ID: 20045721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
    Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
    Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells.
    Garcia R; Yu CL; Hudnall A; Catlett R; Nelson KL; Smithgall T; Fujita DJ; Ethier SP; Jove R
    Cell Growth Differ; 1997 Dec; 8(12):1267-76. PubMed ID: 9419415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.
    Liu CY; Su JC; Ni MH; Tseng LM; Chu PY; Wang DS; Tai WT; Kao YP; Hung MH; Shiau CW; Chen KF
    Breast Cancer Res Treat; 2014 Jul; 146(1):71-84. PubMed ID: 24903225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cryptotanshinone inhibits human glioma cell proliferation in vitro and in vivo through SHP-2-dependent inhibition of STAT3 activation.
    Lu L; Zhang S; Li C; Zhou C; Li D; Liu P; Huang M; Shen X
    Cell Death Dis; 2017 May; 8(5):e2767. PubMed ID: 28492557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.
    Hu Y; Yagüe E; Zhao J; Wang L; Bai J; Yang Q; Pan T; Zhao H; Liu J; Zhang J
    Cancer Lett; 2018 Jun; 423():47-59. PubMed ID: 29496539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3.
    Leslie K; Lang C; Devgan G; Azare J; Berishaj M; Gerald W; Kim YB; Paz K; Darnell JE; Albanese C; Sakamaki T; Pestell R; Bromberg J
    Cancer Res; 2006 Mar; 66(5):2544-52. PubMed ID: 16510571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
    Linher-Melville K; Nashed MG; Ungard RG; Haftchenary S; Rosa DA; Gunning PT; Singh G
    PLoS One; 2016; 11(8):e0161202. PubMed ID: 27513743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cell.
    Kim J; Lee YJ; Shin DS; Jeon SH; Son KH; Han DC; Jung SN; Oh TK; Kwon BM
    Bioorg Med Chem; 2011 Dec; 19(24):7582-9. PubMed ID: 22071520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.